Henry E. Blair
Keine laufenden Positionen mehr
Profil
Henry E.
Blair was the founder of GelTex Pharmaceuticals, Inc. (1991), Dyax Corp.
(1989), and Genzyme Corp.
(1981) where he held the titles of Chairman, and Director respectively.
Mr. Blair is also the founder of Biocode, Inc. Mr. Blair's former jobs include Director positions at Celtrix Pharmaceuticals, Inc., DynaGen, Inc., and rEVO Biologics, Inc. He also served as an Advisor at BioVentures Investors and as a Trustee at Immune Disease Institute, Inc.
Ehemalige bekannte Positionen von Henry E. Blair
| Unternehmen | Position | Ende |
|---|---|---|
| DYAX CORP. | Vorstandsvorsitzender | 01.04.2007 |
BioVentures Investors
 BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Private Equity Investor | 31.03.2009 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Gründer | 24.05.2007 |
Biocode, Inc.
 Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Gründer | - |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The company is based in Santa Clara, CA. | Health Technology |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology GelTex Pharmaceuticals, Inc. was developed non-absorbed, polymer-based pharmaceuticals that selectively bind and eliminate target substances from the intestinal tract. The company is a subsidiary of Geltex Corp. GelTex Pharmaceuticals was founded by Henry E Blair & James B Tananbaum in 1991 and was located in Waltham, MA. | Health Technology |
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| DynaGen, Inc. | Health Technology |
Biocode, Inc.
Biocode, Inc. Office Equipment/SuppliesProducer Manufacturing Biocode identifies counterfeit solid and liquid products using a covert method based on monoclonal antibody technology. And develops techniques to provide brand protection and identification to prevent counterfeitin | Producer Manufacturing |
BioVentures Investors
BioVentures Investors Investment ManagersFinance BioVentures Investors (BioVentures) is a venture capital firm founded in 1997 by Peter J. Feinstein and Marc E. Goldberg. The firm is headquartered in Wellesley, Massachusetts. | Finance |
Immune Disease Institute, Inc.
 Immune Disease Institute, Inc. Immune Disease Institute, Inc. provides biomedical research services. It engages in doing fundamental research to improve human health, harness inflammation, and strengthen immune defense. The company was founded on January 19, 1953 and is headquartered in Boston, MA. | |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
